Welcome to LookChem.com Sign In|Join Free

CAS

  • or

486-35-1

Post Buying Request

486-35-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

486-35-1 Usage

Description

7,8-Dihydroxycoumarin is a naturally occurring coumarin derivative with potential anti-inflammatory and protective properties, particularly for those suffering from lung injury. It is a primary reference substance with assigned absolute purity, considering chromatographic purity, water, residual solvents, and inorganic impurities. The exact purity value can be found on the certificate provided by PhytoLab GmbH & Co. KG.

Uses

Used in Pharmaceutical Industry:
7,8-Dihydroxycoumarin is used as an active pharmaceutical ingredient for its anti-inflammatory and protective properties, particularly in the treatment of lung injury. Its pharmacological effects are attributed to its natural origin as a coumarin derivative, which provides a promising foundation for further research and development in the pharmaceutical sector.
Used in Traditional Chinese Medicine (TCM):
In TCM, 7,8-Dihydroxycoumarin is used as a component in medicines for the treatment of injuries. Its warming and relaxing properties make it suitable for warming the spleen and stomach, as well as promoting circulation and relaxing muscles and joints. This application takes advantage of the compound's natural properties and its traditional use in herbal medicine.
Physical Properties:
7,8-Dihydroxycoumarin appears as a white or off-white powder, which is odorless and tasteless. It has the following solubility properties: slightly soluble in methanol (equilibrium solubility of 485.4 μg/mL), slightly soluble in ethanol (equilibrium solubility of 230.06 μg/mL), and insoluble in water (equilibrium solubility of 176.7 μg/mL). The melting point of 7,8-Dihydroxycoumarin is between 262–264°C.

History

Changbai daphne, a Chinese traditional medicine in clinic, is mainly used for treatment of coronary heart disease, rheumatoid arthritis, thromboangiitis obliterans, etc. Changbai daphne belongs to the first-class protective plants in Jilin province in China, and the rarity restricted the drug development. Scientists tried to find the effective components of Changbai daphne. In 1977, scientists of phytochemistry research group in the Traditional Chinese Medicine research laboratory from Jilin institute of Chinese medicine first successfully isolated the crystalline monomer?– daphnetin?– from the plant. Pharmacological results show that the pharmacological activities of this crystal are equal to Changbai daphne, which suggested the crystal is the main active ingredient . Through the condensation reaction experiment using equimolecular pyrogallic acid, malic acid, and twice the amount of sulfuric acid, under heating reaction, scientists successfully got pale yellow needle daphnetin crystals. From then on artificially synthesized daphnetin has been successfully implemented . A large-scale industrial production can be acquired. The followup researches on the metabolism and pharmacological activity of daphnetin were carried out. In 2009, the State Food and Drug Administration of China approved daphnetin capsule to be used in the clinical.

Indications

This product is contained in national standards for chemical drugs, mainly used in Buerger’s disease, occlusive vascular disease, and coronary heart disease.

Biochem/physiol Actions

7,8-Dihydroxycoumarinan is an inhibitor of protein kinases. It is an active lactone present in plants such as Daphne Korean Nakai, and Thymelaeaceae Daphne. It serves as as analgesic, antiviral and antibacterial agent. 7,8-Dihydroxycoumarinan is found to induce tumor apoptosis via a number of signalling pathways. Thus, it is believed to exhibit antitumor effects. 7,8-Dihydroxycoumarinan might also be useful in treating lung carcinoma. It is also known to be used in treating coagulation disorders and rheumatoid arthritis. 7,8-Dihydroxycoumarinan is known to induce neurite growth and lengthen neuronal survival. It helps in clearing substances inducing necrosis, maintains water-electrolytes balance and energy metabolism. 7,8-Dihydroxycoumarinan is involved in the generation of neurotrophic factor and helps in restoring neuron function.

Pharmacology

Daphnetin pharmacological effect mainly includes: 1. Improvement of the cardiovascular system function; 2. Effects on the central nervous system. Daphnetin also acts on the NF-k B and NFAT signal pathway and results in immune inhibition; it is also used for the treatment of malaria parasite and Pneumocystis carinii infection by chelating to Fe2 + or by acting on ribonucleotide reductase; daphnetin shows bacteriostatic effects on gold grapes, Escherichia coli, Shigella’s blessing, and Pseudomonas aeruginosa by inhibiting succinic acid oxidase in mitochondria in bacteria; daphnetin reduces the incidences of diarrhea in model mice by inhibiting mice gastrointestinal propulsive movement and has a stronger toxic effect on several important aphids . Plasma protein binding of Daphetin is low. The urinary excretion is higher. The distribution volume is relatively larger. Both of metabolism and excretion are rapid. Drug elimination is mainly through the kidney with a half-life of only 15 min. The tissue distributions after intravenous injection and oral administration are equal. Daphnetin may distribute in the brain through the blood-brain barrier. The metabolites have poor stability and low oral bioavailability. People have studied the metabolic pathways and metabolic product. Daphnetin may be the substrates of MRP2 and BCRP transporters, and thus intestinal absorption is affected; in the plasma of rats, the main metabolite are 7-O and 8-O glucoside substitution products which are mediated by UT1A6 and UT1A9. The anti-inflammatory activity of the metabolites is dependent on daphnetin-7-methyl ether.

Clinical Use

It has been verified by a large number of clinical cases that oral daphnetin capsule can significantly improve thromboangiitis obliterans; oral daphnetin has a better curative effect than intramuscular injection of Changbai daphne in patients with angina pectoris due to coronary heart disease. Daphnetin shows an obvious analgesic sedative effect on surgical and nonsurgical pain-relieved patients after intravenous drip or injection of daphnetin; oral daphnetin capsule shows significant therapeutic effects on rheumatoid arthritis.There are no reports about serious adverse reactions. Two cases of whole-body red itch were reported. It sometimes has mild gastrointestinal reaction when continuously used.

Purification Methods

Crystallise it from aqueous EtOH. It can be sublimed. [Beilstein 18/3 V 202.].

Check Digit Verification of cas no

The CAS Registry Mumber 486-35-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,8 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 486-35:
(5*4)+(4*8)+(3*6)+(2*3)+(1*5)=81
81 % 10 = 1
So 486-35-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H6O4/c10-6-3-1-5-2-4-7(11)13-9(5)8(6)12/h1-4,10,12H

486-35-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D4001)  Daphnetin  >90.0%(HPLC)

  • 486-35-1

  • 1g

  • 1,550.00CNY

  • Detail
  • TCI America

  • (D4001)  Daphnetin  >90.0%(HPLC)

  • 486-35-1

  • 5g

  • 4,990.00CNY

  • Detail
  • Sigma

  • (D5564)  7,8-Dihydroxycoumarin  ≥97%, powder

  • 486-35-1

  • D5564-5MG

  • 890.37CNY

  • Detail
  • Sigma

  • (D5564)  7,8-Dihydroxycoumarin  ≥97%, powder

  • 486-35-1

  • D5564-25MG

  • 3,547.44CNY

  • Detail

486-35-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 7,8-dihydroxycoumarin

1.2 Other means of identification

Product number -
Other names 7,8-Dihydroxychromen-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:486-35-1 SDS

486-35-1Synthetic route

Propiolic acid
471-25-0

Propiolic acid

2-hydroxyresorcinol
87-66-1

2-hydroxyresorcinol

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With ytterbium(III) trifluoromethanesulfonate hydrate at 80℃; for 0.0333333h; Reagent/catalyst; Microwave irradiation;98%
With sulfuric acid at 120℃; for 1h;70%
With sulfuric acid at 120℃; for 0.5h;59%
With sulfuric acid at 124 - 126℃; for 0.833333h;53.4%
With sulfuric acid at 125℃; for 0.833333h;
7,8-dibenzyloxycoumarin
104819-86-5

7,8-dibenzyloxycoumarin

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With aluminum tri-bromide In nitrobenzene for 0.0833333h;80%
malic acid
617-48-1

malic acid

2-hydroxyresorcinol
87-66-1

2-hydroxyresorcinol

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With sulfuric acid65%
With sulfuric acid at 120 - 130℃; for 1h;61%
Stage #1: malic acid With sulfuric acid at 20℃; for 0.166667h;
Stage #2: 2-hydroxyresorcinol at 20 - 120℃; for 2h;
40%
2,3,4-trihydroxybenzylaldehyde
2144-08-3

2,3,4-trihydroxybenzylaldehyde

ethyl (triphenylphosphoranylidene)acetate
1099-45-2

ethyl (triphenylphosphoranylidene)acetate

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
for 0.25h; Inert atmosphere; Reflux;65%
for 4h; Reflux; Inert atmosphere;65%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With 2-iodoxybenzoic acid In dimethyl sulfoxide at 25℃; for 2h; Time; regioselective reaction;59%
maleic acid
110-16-7

maleic acid

2-hydroxyresorcinol
87-66-1

2-hydroxyresorcinol

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With sulfuric acid20%
8-formyl-7-hydroxycoumarin
2067-86-9

8-formyl-7-hydroxycoumarin

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With pyridine; sodium hydroxide; dihydrogen peroxide
7,8-Dihydroxy-2-oxo-2H-1-benzopyran-3-carboxylic acid
19484-74-3

7,8-Dihydroxy-2-oxo-2H-1-benzopyran-3-carboxylic acid

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With sodium hydrogensulfite anschliessend mit Schwefelsaeure erhitzen;
7,8-dimethoxy-chromen-2-one
2445-80-9

7,8-dimethoxy-chromen-2-one

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogen iodide In acetic acid for 2h; Heating;20 mg
daphnin
486-55-5

daphnin

A

D-Glucose
2280-44-6

D-Glucose

B

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogenchloride
7-hydroxy-2-oxo-2H-chromen-8-yl β-D-glucopyranoside
20853-56-9, 22059-09-2

7-hydroxy-2-oxo-2H-chromen-8-yl β-D-glucopyranoside

A

D-Glucose
2280-44-6

D-Glucose

B

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogenchloride
pyridine
110-86-1

pyridine

8-formyl-7-hydroxycoumarin
2067-86-9

8-formyl-7-hydroxycoumarin

1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

daphnetin
486-35-1

daphnetin

daphnine

daphnine

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With mineral acid
With emulsin
acetic anhydride
108-24-7

acetic anhydride

pyrogallolaldehyde

pyrogallolaldehyde

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With sodium acetate at 170 - 180℃; Erwaermen des erhaltenen Daphnetin-diacetats mit Schwefelsaeure;
With sodium acetate
2-<3,4-Dihydroxy-phenyl>-chromen-7-on, Anhydro-7,3',4'-trihydroxy-flaven-(4 oder 2)-ol
92439-17-3

2-<3,4-Dihydroxy-phenyl>-chromen-7-on, Anhydro-7,3',4'-trihydroxy-flaven-(4 oder 2)-ol

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl In methanol; phosphate buffer at 25℃; for 0.0138889h; pH=7.4; Kinetics; Further Variations:; Reagents; reaction time; Oxidation;
7-O-(6'-acetoxy-β-D-glucopyranosyl)-8-hydroxycoumarin

7-O-(6'-acetoxy-β-D-glucopyranosyl)-8-hydroxycoumarin

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogenchloride In water for 1h; Heating;
7-O-[6'-O-(3'',4''-dihydroxycinnamoyl)-β-D-glucopyranosyl]-8-hydroxycoumarin

7-O-[6'-O-(3'',4''-dihydroxycinnamoyl)-β-D-glucopyranosyl]-8-hydroxycoumarin

A

caffeic acid
331-39-5

caffeic acid

B

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogenchloride In water for 1h; Heating;
7-hydroxyl-8-O-[α-D-glucopyranosyl]-2H-benzopyran-2-one

7-hydroxyl-8-O-[α-D-glucopyranosyl]-2H-benzopyran-2-one

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With hydrogenchloride; water for 3h; Heating;
8-hydroxy-7-methoxy-2H-chromen-2-one
19492-03-6

8-hydroxy-7-methoxy-2H-chromen-2-one

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: 20 mg / HI / acetic acid / 2 h / Heating
View Scheme
7-methoxy-8-[(3-methyl-2-butenyl)oxy]-2H-1-benzopyran-2-one
76474-93-6

7-methoxy-8-[(3-methyl-2-butenyl)oxy]-2H-1-benzopyran-2-one

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 15 mg / 10percent aq.H2SO4 / 1 h / Heating
3: 20 mg / HI / acetic acid / 2 h / Heating
View Scheme
daphnin
486-55-5

daphnin

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
Acid hydrolysis;
7-hydroxy-2-oxo-2H-chromen-8-yl β-D-glucopyranoside
20853-56-9, 22059-09-2

7-hydroxy-2-oxo-2H-chromen-8-yl β-D-glucopyranoside

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
Acid hydrolysis;
7-O-β-D-glucopyranosyl-8-methoxybenzopyranone
31564-25-7

7-O-β-D-glucopyranosyl-8-methoxybenzopyranone

daphnetin
486-35-1

daphnetin

Conditions
ConditionsYield
With water Acidic conditions;
daphnetin
486-35-1

daphnetin

7,8-dimethoxy-chromen-2-one
2445-80-9

7,8-dimethoxy-chromen-2-one

Conditions
ConditionsYield
In methanol; diethyl ether at 20℃; for 2h;100%
pentanoic anhydride
2082-59-9

pentanoic anhydride

daphnetin
486-35-1

daphnetin

2-oxo-2H-chromene-7,8-diyl dipentanoate

2-oxo-2H-chromene-7,8-diyl dipentanoate

Conditions
ConditionsYield
With pyridine; dmap at 20℃;99%
With pyridine; dmap at 20℃;99%
1-bromomethyl-4-bromobenzene
589-15-1

1-bromomethyl-4-bromobenzene

daphnetin
486-35-1

daphnetin

C23H16Br2O4

C23H16Br2O4

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; Reflux;99%
acetic anhydride
108-24-7

acetic anhydride

daphnetin
486-35-1

daphnetin

2-oxo-2H-chromene-7,8-diyl diacetate
21784-71-4

2-oxo-2H-chromene-7,8-diyl diacetate

Conditions
ConditionsYield
With dmap In pyridine at 20℃;96.7%
With pyridine In dichloromethane92%
With pyridine; dmap at 20℃;51%
benzyl chloride
100-44-7

benzyl chloride

daphnetin
486-35-1

daphnetin

7,8-dibenzyloxycoumarin
104819-86-5

7,8-dibenzyloxycoumarin

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 13h;92%
Dichlorodiphenylmethane
2051-90-3

Dichlorodiphenylmethane

daphnetin
486-35-1

daphnetin

2,2-Diphenyl-[1,3]dioxolo[4,5-h]chromen-8-one
159979-62-1

2,2-Diphenyl-[1,3]dioxolo[4,5-h]chromen-8-one

Conditions
ConditionsYield
at 160℃; for 0.166667h;88.2%
propionic acid anhydride
123-62-6

propionic acid anhydride

daphnetin
486-35-1

daphnetin

2-oxo-2H-chromene-7,8-diyl di-propionate

2-oxo-2H-chromene-7,8-diyl di-propionate

Conditions
ConditionsYield
With pyridine; dmap at 20℃;84%
With pyridine; dmap at 20℃;84%
n-hexanoic anhydride
2051-49-2

n-hexanoic anhydride

daphnetin
486-35-1

daphnetin

2-oxo-2H-chromene-7,8-diyl dihexanoate

2-oxo-2H-chromene-7,8-diyl dihexanoate

Conditions
ConditionsYield
With pyridine; dmap at 20℃;78%
4-((tert-butyldimethylsilyl)oxy)benzoyl chloride
90446-67-6

4-((tert-butyldimethylsilyl)oxy)benzoyl chloride

daphnetin
486-35-1

daphnetin

C35H42O8Si2

C35H42O8Si2

Conditions
ConditionsYield
With dmap In dichloromethane at 0 - 30℃; for 18h;78%
2-bromoanthracene
7321-27-9

2-bromoanthracene

daphnetin
486-35-1

daphnetin

C23H14O4

C23H14O4

Conditions
ConditionsYield
With cesium bicarbonate In toluene at 40℃; for 30h; Inert atmosphere; Irradiation;77%
2-Methoxybenzoyl chloride
21615-34-9

2-Methoxybenzoyl chloride

daphnetin
486-35-1

daphnetin

C25H18O8

C25H18O8

Conditions
ConditionsYield
With dmap In acetonitrile at 0 - 30℃; for 18h;77%
m-anisoyl chloride
1711-05-3

m-anisoyl chloride

daphnetin
486-35-1

daphnetin

C25H18O8

C25H18O8

Conditions
ConditionsYield
With dmap In acetonitrile at 0 - 30℃; for 18h;75%
4-methoxy-benzoyl chloride
100-07-2

4-methoxy-benzoyl chloride

daphnetin
486-35-1

daphnetin

C25H18O8

C25H18O8

Conditions
ConditionsYield
With dmap In acetonitrile at 0 - 30℃; for 18h;74%
3,5-bis(tert-butyldimethylsilyl)oxybenzoyl chloride
340127-55-1

3,5-bis(tert-butyldimethylsilyl)oxybenzoyl chloride

daphnetin
486-35-1

daphnetin

C47H70O10Si4

C47H70O10Si4

Conditions
ConditionsYield
With dmap In dichloromethane at 0 - 30℃; for 18h;73%
prenyl bromide
870-63-3

prenyl bromide

daphnetin
486-35-1

daphnetin

8-Hydroxy-7-isopentenyloxycoumarin
81263-59-4

8-Hydroxy-7-isopentenyloxycoumarin

Conditions
ConditionsYield
With sodium hydrogencarbonate In acetone65%
With sodium hydrogencarbonate 1.) Me2CO, RT, 1 h, 2.) reflux, 24 h; Yield given. Multistep reaction;
trans-geranyl bromide
6138-90-5

trans-geranyl bromide

daphnetin
486-35-1

daphnetin

7-geranyloxy-8-hydroxycoumarin
562818-09-1

7-geranyloxy-8-hydroxycoumarin

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetone at 20℃; for 3h;65%
1-chloromethyl-2-methylbenzene
552-45-4

1-chloromethyl-2-methylbenzene

daphnetin
486-35-1

daphnetin

C25H22O4

C25H22O4

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; Reflux;63%
(2E)-3,7-dimethyl-2-octen-1-ol
1461-04-7

(2E)-3,7-dimethyl-2-octen-1-ol

daphnetin
486-35-1

daphnetin

A

8-[(3,7-dimethyl-2-octenyl)oxy]-7-hydroxy-2H-1-benzopyran-2-one

8-[(3,7-dimethyl-2-octenyl)oxy]-7-hydroxy-2H-1-benzopyran-2-one

B

7-[(3,7-dimethyl-2-octenyl)oxy]-8-hydroxy-2H-1-benzopyran-2-one

7-[(3,7-dimethyl-2-octenyl)oxy]-8-hydroxy-2H-1-benzopyran-2-one

C

7,8-Bis-((E)-3,7-dimethyl-oct-2-enyloxy)-chromen-2-one

7,8-Bis-((E)-3,7-dimethyl-oct-2-enyloxy)-chromen-2-one

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 10 - 20℃; Mitsunobu reaction; sonication;A 30%
B 61%
C 4%
3-iodocarbazole
16807-13-9

3-iodocarbazole

daphnetin
486-35-1

daphnetin

C21H13NO4

C21H13NO4

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydroxide In toluene at 50℃; for 36h; Inert atmosphere; Irradiation;60%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

daphnetin
486-35-1

daphnetin

2-oxo-2H-chromene-7,8-diyl dibutyrate

2-oxo-2H-chromene-7,8-diyl dibutyrate

Conditions
ConditionsYield
With pyridine; dmap at 20℃;58%
With pyridine; dmap at 20℃;58%
4-Methylbenzyl bromide
104-81-4

4-Methylbenzyl bromide

daphnetin
486-35-1

daphnetin

7,8-bis((4-methylbenzyl)oxy)-2H-chromen-2-one

7,8-bis((4-methylbenzyl)oxy)-2H-chromen-2-one

Conditions
ConditionsYield
Stage #1: daphnetin With potassium carbonate In acetone at 20℃; for 0.5h;
Stage #2: 4-Methylbenzyl bromide In acetone at 65℃;
58%
1-chloromethyl-3-methyl-benzene
620-19-9

1-chloromethyl-3-methyl-benzene

daphnetin
486-35-1

daphnetin

7,8-bis((4-methylbenzyl)oxy)-2H-chromen-2-one

7,8-bis((4-methylbenzyl)oxy)-2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; Reflux;58%
methanol
67-56-1

methanol

Farnesol
106-28-5

Farnesol

daphnetin
486-35-1

daphnetin

A

8-hydroxy-7-methoxy-2H-chromen-2-one
19492-03-6

8-hydroxy-7-methoxy-2H-chromen-2-one

B

7,8-dimethoxy-chromen-2-one
2445-80-9

7,8-dimethoxy-chromen-2-one

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 10 - 20℃; Mitsunobu reaction; sonication;A 52%
B 10%
ethylene dibromide
106-93-4

ethylene dibromide

daphnetin
486-35-1

daphnetin

7,8-(2',3'-dihydro-1',4'-dioxino)coumarin
53324-43-9

7,8-(2',3'-dihydro-1',4'-dioxino)coumarin

Conditions
ConditionsYield
With potassium hydroxide In water Heating;47%
daphnetin
486-35-1

daphnetin

(2R,3R)-2-(4-Hydroxy-3-methoxy-phenyl)-3-hydroxymethyl-2,3-dihydro-1,4,5-trioxa-phenanthren-6-one

(2R,3R)-2-(4-Hydroxy-3-methoxy-phenyl)-3-hydroxymethyl-2,3-dihydro-1,4,5-trioxa-phenanthren-6-one

Conditions
ConditionsYield
With Na,K-phosphate buffer; horseradish peroxidase at 37℃; for 168h;43.1%

486-35-1Relevant articles and documents

Coumarins from the bark of Daphne marginata

Zhang, Wei,Shen, Yunheng,Liu, Runhui,Zhang, Chuan,Chen, Haisheng,Fu, Peng,Shan, Lei,Zhang, Weidong

, p. 317 - 318 (2007)

-

-

Sato,Hasegawa

, p. 2367,2372 (1971)

-

Antagonistic activity of hydroxycoumarin-based antioxidants as possible singlet oxygen precursor photosensitizers

Guerrero, Tomás,Vázquez-Ortega, Fernanda,Lagunes, Irene,Ortiz-Blanco, Erik,Sosa-Ortiz, Gabriela,Tovar-Miranda, Ricardo,Medina, Manuel E.,Trigos, ángel

, (2021/05/10)

Coumarins are phenolic-type compounds with efficient antioxidant activity due to their ability to scavenge reactive oxygen species. Nevertheless, their ability to behave as photosensitizers capable of generating reactive oxygen species, such as singlet oxygen, has been less studied. In this work, the photosensitizing ability of seven hydroxycoumarins was evaluated through the photooxidation of ergosterol by quantifying the conversion of ergosterol into ergosterol peroxide. In our experimental conditions, we found that almost every tested antioxidant coumarin promotes the peroxidation of ergosterol. The results suggest that the hydroxycoumarins exhibit potential photosensitizing activity by promoting singlet oxygen generation by a Type II photochemical mechanism. Density functional theory (DFT) calculations were also performed to obtain further insight into the chemical reactivity of tested compounds; the observed tendency in the group of antioxidant coumarins to promote the reaction was their hardness due to the principle of maximum hardness. To evaluate our conclusion, we performed the reaction using a highly polarizable coumarin as a photosensitizer, which resulted in an increased photosensitizing capacity supported with DFT calculations, which reinforces our analysis. Finally, we found that hydroxycoumarins can be potentially pro-oxidants since some of them can act as photosensitizers and generate singlet oxygen in the presence of UV–Vis light, a characteristic that must be considered when these compounds are used as antioxidants.

Tumor diagnosis and treatment fluorescent probe for targeting tumor Wolburg effect

-

Paragraph 0048-0053, (2020/11/02)

The invention discloses a tumor diagnosis and treatment fluorescent probe for targeting tumor Warburg effect, and the structure of the fluorescent probe is shown as a formula (I). The fluorescent probe can be directly used in a cell line to analyze and detect the expression degree of tumor cell GLUT1 protein, so as to complete the screening of tumor cells. Meanwhile, tumor cell proliferation is inhibited by directly blocking the GLUT1 channel to inhibit intake of sugar nutritional ingredients by tumors. And an effective means and a useful tool are provided for early screening and diagnosis oftumors, development of new anti-tumor drugs and the like.

Solubility of Collinin and Isocollinin in Pressurized Carbon Dioxide: Synthesis, Solubility Parameters, and Equilibrium Measurements

Pardo-Casta?o, Camilo,García, Andrés C.,Benavides, Paola,Bola?os, Gustavo

, p. 3799 - 3810 (2019/09/30)

Collinin is a derivative of coumarin that has shown remarkable potential against cancer, tuberculosis, periodontitis, and other prevalent diseases, and is usually extracted from plants of the Rutaceae family at a very low yield. In this work, collinin and a position-isomer herein called isocollinin were synthesized at different scales (from 1 to 50 g of precursor) by a route consisting of two parallel and two sequential chemical reactions. The isomers were characterized by 1H NMR, 13C NMR, nuclear Overhauser enhancement spectroscopy NMR, melting temperature, and melting enthalpy. For each isomer, the Hansen solubility parameters and the radius of its solubility sphere were experimentally determined by solubility tests in 15 common solvents and two solvent blends. The solubility of each isomer in pressurized CO2 was determined at 30 and 50 °C from 72.2 to 112.9 bar, by an in situ high-pressure spectrometry technique, which was validated with the anthracene-CO2 system. The solubility of both isomers in CO2 increased with pressure in the range of temperatures and pressures considered, but that of collinin exhibited an asymptotic behavior around 80.8 and 104.8 bar, at 30 and 50 °C, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 486-35-1